Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial.

Published in: American journal of clinical dermatology (2024)

NCT04061252 (Date of Trial Registration: August 19, 2019).

Keyphrases